Literature DB >> 17671430

Bin1 interacts with and restrains the DNA end-binding protein complex Ku.

Arivudainambi Ramalingam1, George E Farmer, Thomas D Stamato, George C Prendergast.   

Abstract

The Bin1 gene encodes a BAR adapter protein that suppresses cancer by poorly defined mechanisms. In an effort to gain insights, we identified cellular proteins that form biochemical complexes with Bin1 protein. Here we report that Bin1 physically binds to Ku, a DNA end-binding protein that functions in telomere maintenance, apoptosis, and DNA repair. Both Ku70 and Ku80 were purified from human and murine cell extracts using the Bin1 BAR domain as an affinity matrix. A BAR domain mutation that destroys antioncogenic activity completely abolished Ku binding, supporting functional relevance. To further evaluate meaning, we investigated interactions between the Bin1 homolog hob1+ and the Ku homologs pku70+ and pku80+ in fission yeast. Notably, deleting pku70+ or pku80+ relieved the survival defect displayed by hob1delta cells after treatment with the DNA damaging agent phleomycin, suggesting that hob1+ may restrain Ku. Consistent with this notion, telomere length was altered in hob1delta cells. The potential relevance of Bin1-Ku interaction to cancer are discussed in light of these findings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671430     DOI: 10.4161/cc.6.15.4514

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  8 in total

1.  Bin1 SRC homology 3 domain acts as a scaffold for myofiber sarcomere assembly.

Authors:  Pasan Fernando; Jacqueline S Sandoz; Wen Ding; Yves de Repentigny; Steve Brunette; John F Kelly; Rashmi Kothary; Lynn A Megeney
Journal:  J Biol Chem       Date:  2009-07-26       Impact factor: 5.157

Review 2.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

3.  Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.

Authors:  Watson P Folk; Alpana Kumari; Tetsushi Iwasaki; Slovénie Pyndiah; Joanna C Johnson; Erica K Cassimere; Amy L Abdulovic-Cui; Daitoku Sakamuro
Journal:  J Biol Chem       Date:  2019-02-07       Impact factor: 5.157

Review 4.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

Review 5.  BAR the door: cancer suppression by amphiphysin-like genes.

Authors:  George C Prendergast; Alexander J Muller; Arivudanambi Ramalingam; Mee Young Chang
Journal:  Biochim Biophys Acta       Date:  2008-09-18

Review 6.  Amphiphysin 2 (BIN1) in physiology and diseases.

Authors:  Ivana Prokic; Belinda S Cowling; Jocelyn Laporte
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

7.  Ndm, a coiled-coil domain protein that suppresses macropinocytosis and has effects on cell migration.

Authors:  Jessica S Kelsey; Nathan M Fastman; Elizabeth F Noratel; Daphne D Blumberg
Journal:  Mol Biol Cell       Date:  2012-07-18       Impact factor: 4.138

8.  Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.

Authors:  Kathleen M McAvoy; Hameetha Rajamohamed Sait; Galina Marsh; Michael Peterson; Taylor L Reynolds; Jake Gagnon; Sarah Geisler; Prescott Leach; Chris Roberts; Ellen Cahir-McFarland; Richard M Ransohoff; Andrea Crotti
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.